Drug Trial Radar · NCT03533257
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
95
Actual
Start
Sep 14, 2018
Primary completion
Oct 22, 2020
Study completion Nov 6, 2020
Sponsor
- Lead sponsor
- Amylyx Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Alzheimer's Drug Discovery Foundation; Alzheimer's Association
- First posted
- May 23, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD).
Conditions
- Alzheimer Disease
Interventions
AMX0035Drug
Combination Therapy of PB and TURSO
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Event (TEAEs)Time frame: From first dose to 24 weeks
- Effect of Treatment on a Global Composite Statistical Test of Cognition, Function, and Neuroanatomy (GST)Time frame: 24 weeks
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Clinical Neuroscience Solutions, Inc. - Jacksonville
Jacksonville, Florida
Clinical Neuroscience Solutions, Inc. - Orlando
Orlando, Florida
International Medical Investigational Centers (IMIC)
Palmetto Bay, Florida
Rush University Medical Center
Chicago, Illinois
University of Kansas Clinical Research Center
Fairway, Kansas
Massachusetts General Hospital
Boston, Massachusetts
Rowan University School of Osteopathic Medicine
Stratford, New Jersey
Mount Sinai Alzheimer's Disease Research Center
New York, New York
Columbia University
New York, New York
Hospital of the University of Pennsylvania, Penn Memory Center
Philadelphia, Pennsylvania
Genesis NeuroScience Clinic
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.